Sandostatin LAR

Sandostatin LAR Indications/Uses

octreotide

Manufacturer:

Novartis Healthcare

Distributor:

Novartis Healthcare
Full Prescribing Info
Indications/Uses
Treatment of patients with acromegaly: in whom surgery or radiotherapy is inappropriate or ineffective, or in the interim period until radiotherapy becomes fully effective.
Treatment of patients with symptoms associated with functional gastro-entero-pancreatic endocrine tumors: Carcinoid tumors with features of the carcinoid syndrome, VIPomas, Glucagonomas, Gastrinomas/Zollinger-Ellison syndrome, Insulinomas, for pre-operative control of hypoglycemia and for maintenance therapy, GRFomas.
Treatment of patients with advanced Neuroendocrine Tumors of the midgut or unknown primary tumor location.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in